A new agreement between the FDA and Avidity Biosciences could further assuage industry concerns about the agency’s stance on ...

Molecular diagnosis of HAV along with anti-HAV IgG avidity measurement are helpful in case of positive IgM where laboratory evidence of acute hepatitis is absent and there is no epidemiologic link ...

Avidity shares early del-brax FSHD data showing improved mobility, strength, and safety; Phase 3 FORWARD trial now underway.

Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the 13 Biotech Stocks with Huge Upside Potential. Raymond James has started ...

Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space — a first for the company's RNA platform. Please watch the video at ...

One of the key players, Avidity Biosciences, is feeling particularly bullish about its chances. Last month, Fulcrum ...

Shares of Avidity Biosciences Inc. soared 39% in premarket trading on Wednesday after the company said its experimental RNA therapy, when injected into the muscle, has potential as a treatment for ...

Avidity Biosciences, Inc. RNA provided an update on its phase I/II study of AOC 1001 in adults with myotonic dystrophy type I (DM1). The company reported that it is engaged in ongoing discussions ...

Shares of Avidity Biosciences Inc. tumbled 23.7% in premarket trading on Tuesday after the company said the Food and Drug Administration placed a partial clinical hold on new enrollment in a Phase ...

Affinity and avidity are two terms used in immunology and microbiology to describe binding strength between an antibody and antigen. Because both affinity and avidity involve binding strength, the two ...

Bristol Myers Squibb seems to have found a friend in Avidity Biosciences, as the two add a second link to a heart-focused research partnership for $100 million upfront. The two companies tied the ...